Caliper Debuts LabChip For Drug Discovery; Waits On Molecular Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
The appointment of Daniel Kisner, PhD, as chief executive officer of Caliper Technologies reflects the company's intention to keep its LabChip technology focused on pharmaceutical applications while long-term development in diagnostics continues.